People · Operator
Named in public records as an officer, director or promoter · active 2009–2026 · Other Health Care, Other, Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Compliant Innovations, Inc | — | Other Health Care | Series A | $9.6M | $88.2M | 2022 |
| ZeroCarb Inc. | — | Other | Seed | $5.2M | $495K | 2023 |
| Antigenix Therapeutics, Inc. | — | Pharma | Seed | $3.4M | $8.1M | 2025 |
| Immuneworks, Inc. | — | Biotechnology | Pre-Seed | $375K | $20.7M | 2009 |
Shaun Hawkins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shaun Hawkins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tamir Meiri | 1 | 5 |
| John Pena | 1 | 2 |
| Mohamed Aly | 1 | 2 |
| Ronald L. Meeusen | 1 | 2 |
| Kevin Duncan | 1 | 2 |
| Sy Fahimi | 1 | 2 |
| Christopher Whitfield | 1 | 1 |
| Ken Trauner | 1 | 1 |
| Samuel Ethiopia | 1 | 1 |
| Wade A. Lange | 1 | 1 |
| Michael J. Klemsz | 1 | 1 |
| Haytham Mohamed | 1 | 1 |
| David S. Wilkes | 1 | 1 |
| Bob Kirch | 1 | 1 |
| Omar Atia | 1 | 1 |
| Leslie Hawkins | 1 | 1 |
| Wesam Saber | 1 | 1 |
| Kwesi Frimpong-Boateng | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.